Author Question: The nurse is teaching a client who is prescribed sumatriptan therapy for treatment of migraine ... (Read 39 times)

Tazate · **on:** Jul 23, 2018

The nurse is teaching a client who is prescribed sumatriptan therapy for treatment of migraine headaches. The nurse instructs the client to take the drug at which time?

1. At the first sign of aura or headache
2. First thing in the morning if expecting a headache
3. When the client can lie down for one hour after taking the drug
4. About 30 minutes after the start of the headache

Question 2

The nurse is teaching a group of student nurses the role of naloxone in treating opioid toxicity. How should the nurse explain the mechanism of action?

1. Naloxone blocks the pain transmission sites.
2. Naloxone competes with the opioid at the receptor sites.
3. Naloxone binds with the opioid to prevent the action of the opioid.
4. Naloxone blocks the pain perception of the client.

janeli · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 1
Rationale 1: The client should take the medication at the first sign of aura or headache for it to be most effective.
Rationale 2: The client should take the medication at the first sign of a headache, not if expecting one.
Rationale 3: The client does not need to be able to lie down after taking sumatriptan.
Rationale 4: The client should not wait this long to take the medication.
Global Rationale: The client should take the medication at the first sign of aura or headache for it to be most effective. The client should not take the medication prior to symptoms. The client does not need to be able to lie down after taking sumatriptan nor does the client need to wait 30 minutes after symptoms begin before taking the medication.

Answer to Question 2

Correct Answer: 2
Rationale 1: Naloxone does not work in the transmission of pain.
Rationale 2: Naloxone competes with the opioid at the mu and kappa receptor sites.
Rationale 3: Naloxone does not bind with the opioid.
Rationale 4: Naloxone does not block the pain perception of the client.
Global Rationale: Naloxone competes with the opioid at the mu and kappa receptor sites. Naloxone does not work in the transmission of pain, does not bind with the opioid, and does not block the pain perception of the client.